* Study leader says both drugs show very similar results
(Adds further comment from study leader, more on sales
prospects)
The post UPDATE 1-Novartis challenges Pfizer with strong breast cancer drug data appeared first on NASDAQ.
UPDATE 1-Novartis challenges Pfizer with strong breast cancer drug data
